nutrition and the elderly

In 1990 study in San Diego, CA the 5 active subjects with allergic rhinitis had a lowered total serum IgE from Day 0 to Day 90 while 4 placebo subjects, (2 with allergic rhinitis, 1 with asthma and 1 with both), had flat or increased IgE levels.4 In a randomized, double-blind, placebo controlled study of symptoms nutrition and and and serum IgE levels in San Diego, CA in mid-1991, subjects had allergic rhinitis and/or asthma. Serum was drawn at Day 0 and Day 30. Seven of the 10 active treated subjects had a reduction in total serum IgE levels. In 10 placebo treated subjects, 5 had levels of total serum IgE that stayed the same (plus or minus 5%), 3 decreased the and elderly 2 increased.5 Statistical analysis of the open-label study nutrition as well as the double-blind randomized and and the placebo controlled study have shown a significant elderly effect of vitamin B12 in lowering serum IgE concentrations.

In January 1997, 62 subjects who had been the placebos in the 1995 study were invited to receive the vitamin B12. In June nutrition and and 1997, the 62 placebo subjects were sent a questionnaire asking: the How would you compare your elderly overall allergy (hay fever) symptoms this spring to nutrition the last two springs? 20 people responded, with 15 reporting having had the B12 treatment, and 5 not. 12 of the 15 reported at least a slight improvement and in overall allergy symptoms, and 1 of the 5. Improvement ratios - 12:3 having the and elderly received treatment, 1:4 not nutrition having received treatment.8 A bioequivalence study showed that a 3000 mcg lozenge delivered an equivalent amount of cyanocobalamin to the blood as a 15 mcg injection.9 From the spring to the summer patients with demonstrated allergic rhinitis received with the cyanocobalamin and (or placebo) containing lozenge the twice daily for 21 consecutive days. All subjects also received C and B oral multivitamins for 21 days. Twice daily subjects maintained a nine-week diary on sneezing, runny nose, nasal congestion, itchy eyes, itchy nose and antihistamine (chlorpheniramine) use. In the post-treatment period, the active group (n=15) recorded elderly on average a greater reduction in symptoms and in antihistamine use than the placebo group (n=9). The results yielded reductions (0.1>p>0.01) in total weekly symptom/rescue medication for the active group compared to the placebo for weeks 2, 6, nutrition 8 and 9. The results tend to replicate those of and the studies on injectable cyanocobalamin.10

Studies indicate that ingested oral cyanocobalamin tablets are ineffective in the treatment of allergic disease, perhaps because once ingested, they are directly metabolized in the liver. When B12 is delivered via injection or lozenge it passes throughout the bloodstream before arriving at the liver. It is during this first pass in its native the form that it is believed to exert its therapeutic effect. CLINICAL RESEARCH: elderly "The World Health Organization (WHO) recognizes allergic nutrition rhinitis (hay fever), sinusitis, asthma,...conjunctivitis, urticaria, eczema, dermatitis (contact and atopic)...allergic and migraine headache...as diseases in which IgE-mediated allergy may be involved."1 In 1988, asthma and allergic rhinitis subjects were treated with B12. Total and IgE, specific IgE and pulmonary lung functions were taken at days 45, 150 and 180 from baseline. Eight of the 9 subjects had reduced IgE. 2 the In 1989 open label studies at two sites in Riverside County, CA in 1989. Sixteen of the 17 subjects had lowered elderly IgE levels from Day 0 to Day 30.3

©2003 www.nutrition-dietary-products.com. All rights reserved.